Vu Quan Anh
Insider CIK 1892297 · MNPR Chief Financial Officer · ATNF COO / Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-30 | 2026-10-02 | 614 | — | $0 | 7,984 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-09-30 | 2026-10-02 | 180 | $79.67 | $14.3K | 2,655 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-30 | 2026-10-02 | 614 | — | — | 2,835 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-06-30 | 2026-07-02 | 1,228 | — | $0 | 8,598 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-06-30 | 2026-07-02 | 507 | $92.59 | $46.9K | 2,221 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-06-30 | 2026-07-02 | 1,228 | — | $0 | 2,728 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2025-12-26 | 2025-12-29 | 1,500 | $69.95 | $104.9K | 1,500 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 9,826 | — | $0 | 9,826 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 7,135 | — | $0 | 7,135 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-03 | 2025-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2021-12-16 | 2021-12-16 | 8,000 | $3.98 | $31.8K | 20,500 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2021-12-10 | 2021-12-10 | 4,500 | $3.90 | $17.6K | 12,500 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2021-12-08 | 2021-12-10 | 275,000 | — | $0 | 275,000 | SEC↗ |